{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:54:49Z","timestamp":1791874489620,"version":"4.3.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,7,22]],"date-time":"2013-07-22T00:00:00Z","timestamp":1374451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"name":"UGC (BSR), Government of India, and New Delhi"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.jpha.2013.04.008","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T22:54:17Z","timestamp":1369263257000},"page":"394-401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Simultaneous determination of asenapine and valproic acid in human plasma using LC\u2013MS\/MS: Application of the method to support pharmacokinetic study"],"prefix":"10.1016","volume":"3","author":[{"given":"Ambavaram Vijaya Bhaskar","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandigam","family":"Venugopal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajulapalle","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jpha.2013.04.008_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11920-008-0012-7","article-title":"Bipolar disorder and suicide: research synthesis and clinical translation","volume":"10","author":"McIntyre","year":"2008","journal-title":"Curr. Psychiatry Rep."},{"issue":"3","key":"10.1016\/j.jpha.2013.04.008_bib2","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1176\/appi.ajp.2007.05081484","article-title":"The prospective course of rapid-cycling bipolar disorder: findings from the STEP-BD","volume":"165","author":"Schneck","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpha.2013.04.008_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0091-3057(90)90298-V","article-title":"Actions of ORG 5222 as a novel psychotropic agent","volume":"35","author":"Costall","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.jpha.2013.04.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.psy.0000151489.36347.18","article-title":"Psychiatric and medical comorbidities of bipolar disorder","volume":"67","author":"Krishnan","year":"2005","journal-title":"Psychosom. Med."},{"issue":"3","key":"10.1016\/j.jpha.2013.04.008_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/10673221003747955","article-title":"Bipolar depression: overview and commentary","volume":"18","author":"Baldessarini","year":"2010","journal-title":"Harv. Rev. Psychiatry"},{"issue":"8","key":"10.1016\/j.jpha.2013.04.008_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.4088\/JCP.v68n0811","article-title":"Mood symptoms, functional impairment, and disability in people with bipolar disorder: specific effects of mania and depression","volume":"68","author":"Simon","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpha.2013.04.008_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","article-title":"Suicidal behaviour in bipolar disorder: risk and prevention","volume":"17","author":"Tondo","year":"2003","journal-title":"CNS Drug"},{"issue":"10","key":"10.1016\/j.jpha.2013.04.008_bib8","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4088\/JCP.v68n1004","article-title":"Efficacy and tolerability of asenapine in acute schizophrenia: a placebo and risperidone controlled trial","volume":"68","author":"Potkin","year":"2007","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpha.2013.04.008_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.64719\/pb.4120","article-title":"Asenapine in the treatment of negative symptoms of schizophrenia: clinical trial design and rationale","volume":"40","author":"Alphs","year":"2007","journal-title":"Psychopharmacol. Bull."},{"issue":"7","key":"10.1016\/j.jpha.2013.04.008_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"issue":"4","key":"10.1016\/j.jpha.2013.04.008_bib11","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.clinbiochem.2004.11.007","article-title":"Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry","volume":"38","author":"Taylor","year":"2005","journal-title":"Clin. Biochem."},{"issue":"2","key":"10.1016\/j.jpha.2013.04.008_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jpba.2007.02.006","article-title":"Recent advances in high-throughput quantitative bioanalysis by LC\u2013MS\/MS","volume":"44","author":"Xu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"2","key":"10.1016\/j.jpha.2013.04.008_bib13","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jpha.2012.09.001","article-title":"Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: application to a pharmacokinetic study","volume":"3","author":"Santosh","year":"2013","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.jpha.2013.04.008_bib14","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.jpha.2012.11.003","article-title":"LC\u2013MS\/MS assay for the determination of natamycin in rabbit and human plasma: application to a pharmacokinetics and protein binding study","volume":"3","author":"Yashpal","year":"2013","journal-title":"J. Pharm. Anal."},{"issue":"2","key":"10.1016\/j.jpha.2013.04.008_bib15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/bmc.1640","article-title":"Quantification of asenapine and three metabolites in human plasma using liquid Chromatography-tandem mass spectrometry with automated solid-phase extraction: application to a phase I clinical trial with asenapine in healthy male subjects","volume":"26","author":"De Boer","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpha.2013.04.008_bib16","unstructured":"U.S. Department of Health and Human Services. Food and Drug Administration Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), BP. May 2001."},{"issue":"7","key":"10.1016\/j.jpha.2013.04.008_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/11590490-000000000-00000","article-title":"Asenapine pharmacokinetics in hepatic and renal impairment","volume":"50","author":"Peeters","year":"2011","journal-title":"Clin. Pharmacokinet."},{"issue":"19","key":"10.1016\/j.jpha.2013.04.008_bib18","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1158\/1078-0432.CCR-10-1238","article-title":"Pharmacokinetic and pharmacodynamic evaluation of combined valproic acid\/doxorubicin treatment in dogs with spontaneous cancer","volume":"16","author":"Wittenburg","year":"2010","journal-title":"Clin. Cancer Res."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177913000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095177913000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T21:26:57Z","timestamp":1761859617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095177913000543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2095177913000543"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2013.04.008","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous determination of asenapine and valproic acid in human plasma using LC\u2013MS\/MS: Application of the method to support pharmacokinetic study","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2013.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Xi'an Jiaotong University. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}